Motoharu Shibusawa, Tetsuya Tanimoto. "Quizartinib for Newly Diagnosed
                    <i>FLT3</i>
                    -Internal Tandem Duplication–Negative AML." Journal of Clinical Oncology, 2026. doi:10.1200/jco-25-02702